 |
|
Long-term Therapeutic Effect of Intravitreal Bevacizumab (Avastin) on Myopic Choroidal Neovascularization.
Young Seung Seo, Moo Hwan Chang
J Korean Ophthalmol Soc. 2011;52(1):34-40. Published online 2011 Jan 15 DOI: https://doi.org/10.3341/jkos.2011.52.1.34
|
|
Citations to this article as recorded by
 Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification
Sujin Yeo, Jong Min Kim
Journal of the Korean Ophthalmological Society.2023; 64(6): 514. CrossRef Long-term Treatment Outcomes of Intravitreal Bevacizumab Treatment for Myopic Choroidal Neovascularization
Jeong Min Lee, Jong Woo Kim, Dong Won Lee, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2019; 60(6): 547. CrossRef Comparison of Two Doses of IVB and Prognostic Factor on Myopic CNV : 1-Year Outcome
Eun Hae Lim, Yoon Soo Jang, Young Ju Lew, Su Jin Yoo
Journal of the Korean Ophthalmological Society.2012; 53(12): 1807. CrossRef
|